Shattuck Labs Inc — Quarterly Cash Flow (NASDAQ:STTK) | MetaTrader

Open full chart

Financials

Overview Rapor Statistics

Quarterly Annual

Total assets 91.05 M77.17 M64.37 M100.33 M91.03 M Total liabilities 11.42 M9.58 M7.35 M7.09 M8.64 M Total equity 79.63 M67.59 M57.02 M93.24 M82.39 M Total liabilities & shareholders' equities 91.05 M77.17 M64.37 M100.33 M91.03 M Total debt ————— Net debt —————

Haberler

Shattuck Labs: Surviving In An AI World Is Going To Be Tough (NASDAQ:STTK)

TD Cowen, Shattuck Labs için Al tavsiyesini korudu

Shattuck Labs stock maintained at Buy by TD Cowen on drug data

Piper Sandler, Shattuck Labs hissesini Ağırlık Üstü tavsiyesiyle takibe aldı

Piper Sandler initiates Shattuck Labs stock with Overweight rating

Shattuck Labs: "Hold" On Oncology Exit And Competitive TL1A/DR3 Pathway Pivot (STTK)

Earnings season to kick off with

Shattuck's Bowel Disease Treatment Looks Promising: Analyst - Shattuck Labs (NASDAQ:STTK)

H.C. Wainwright, Shattuck Labs hissesini Alım tavsiyesine yükseltti

Shattuck Labs stock rating upgraded to Buy by H.C. Wainwright

Shattuck Labs, Inc. (STTK) Presents at The United European Gastroenterology (UEG) Congress UEG Week 2025 Transcript

Shattuck Labs UEG Kongresi’nde: Yenilikçi IBD Tedavisi Hakkında Bilgiler